AMERICAN SHARED HOSPITAL SERVICES Proceeds from Lines of Credit
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Proceeds from Lines of Credit of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-08-13
- AMERICAN SHARED HOSPITAL SERVICES proceeds from lines of credit for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from lines of credit for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from lines of credit for the quarter ending 2025-12-31 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from lines of credit for the quarter ending 2025-09-30 was $2.00M, a 55.56% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from lines of credit for fiscal 2025 was $9.00M, a 17.43% decline from fiscal 2024.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from lines of credit for fiscal 2024 was $10.90M, a 179.49% increase from fiscal 2023.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from lines of credit for fiscal 2023 was $3.90M.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from lines of credit for fiscal 2022 was $0.00.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $2.00M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $2.00M derived: sum of 3 quarters · filed 2026-05-14 | $7.00M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $2.00M derived: sum of 2 quarters · filed 2026-03-31 | $7.00M derived: sum of 3 quarters · filed 2026-08-13 | $9.00M 10-K · filed 2026-03-31 |
| 2025-09-30 | $2.00M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-01-16 | $7.00M derived: sum of 2 quarters · filed 2026-08-13 | $9.00M 10-Q/A · filed 2026-01-16 | $9.00M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $7.00M 10-Q · filed 2026-08-13 | $7.00M derived: sum of 3 quarters · filed 2026-08-13 | $11.50M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $2.00M 10-Q · filed 2026-05-14 | $2.00M derived: sum of 2 quarters · filed 2026-05-14 | $6.50M derived: sum of 3 quarters · filed 2026-05-14 | $10.50M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $4.50M derived: sum of 2 quarters · filed 2026-03-31 | $8.50M derived: sum of 3 quarters · filed 2026-03-31 | $10.90M 10-K · filed 2026-03-31 |
| 2024-09-30 | $4.50M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-01-16 | $8.50M derived: sum of 2 quarters · filed 2026-01-16 | $10.90M 10-Q/A · filed 2026-01-16 | $13.40M derived: sum of 4 quarters · filed 2026-01-16 |
| 2024-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $6.40M 10-Q · filed 2025-08-13 | $8.90M derived: sum of 3 quarters · filed 2025-08-13 | $10.30M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $2.40M 10-Q · filed 2025-05-15 | $4.90M derived: sum of 2 quarters · filed 2025-05-15 | $6.30M derived: sum of 3 quarters · filed 2025-05-15 | $6.30M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $3.90M derived: sum of 2 quarters · filed 2025-04-04 | $3.90M derived: sum of 3 quarters · filed 2025-04-04 | $3.90M 10-K · filed 2025-04-04 |
| 2023-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.40M derived: sum of 2 quarters · filed 2024-11-14 | $1.40M 10-Q · filed 2024-11-14 | $1.40M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2024-08-14 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |